metabolic
NASH and GLP-1 Medications
NASH is the inflammatory, progressive form of NAFLD that can lead to cirrhosis. GLP-1 medications are becoming a cornerstone of NASH treatment.
40-60%
NASH resolution
20-40%
Fibrosis improvement
Significant
Progression prevention
NASH Treatment Benefits
NASH involves liver inflammation and damage beyond simple fat accumulation. GLP-1 medications resolve NASH in 40-60% of patients. They reduce liver fat, inflammation, and fibrosis markers. Tirzepatide shows particular promise for NASH resolution. Weight loss of 7-10% is the primary treatment target. GLP-1s achieve this consistently while improving metabolic health. They may prevent progression to cirrhosis and liver cancer.
Monitoring and Care
Liver specialists should monitor NASH treatment. Repeat FibroScan or imaging at 12 months. Liver enzymes typically normalize within 3-6 months. Biopsy may be repeated after 18-24 months to confirm resolution. SeraVia Detox+ Shield supports liver health.
Medications commonly used
Find providers who understand nash
Compare GLP-1 providers by clinical oversight, medication options, pricing, and local availability.